Plain-English translation of NCT06928909 on ClinicalTrials.gov ↗ ·
This study is evaluating whether a leukemia treatment guideline based on international best practices works well for children with acute myeloid leukemia (AML) in Malawi. Researchers will collect information about children receiving standard treatment at Kamuzu Central Hospital to understand how effectively the treatment plan helps patients and what challenges families face. The goal is to make sure children in resource-limited settings get the best possible care for this serious blood cancer.
Children with leukemia in low-resource countries often have different treatment outcomes than those in wealthier nations, sometimes because treatment plans aren't adapted to local settings. This study exists to see whether a treatment approach designed specifically for hospitals with limited resources actually works well in practice and helps improve survival for children like yours.
You likely qualify if…
You likely don't qualify if…
If you enroll, you and your child will receive standard leukemia treatment at the hospital — no extra procedures will be added because of the study. Researchers will collect information that is already being gathered as part of routine care, such as bone marrow test results, blood counts, physical measurements, and how your child is doing. You'll be asked to share this medical information so doctors can learn what works best for treating children with leukemia in settings like yours.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Malawi